Surgical treatment of XXXX .

@entity1 @entity82 @entity1956 @entity96 @entity1575 @entity5 @entity409 @entity532 @entity209 @entity157
The incidence of @entity157 ( @entity157 ) in Europe and throughout the world is currently increasing. This is caused by an increase in the number of @entity1 with @entity409 , @entity209 , and by increasing incidence of @entity1956 and C.From January 1, 2004 to December 31, 2013, resection or radiofrequency ablation of the liver was done in 360 @entity1 with benign lesions or @entity96 . In 28 @entity1 @entity157 was diagnosed and histologically confirmed (7.8 %). Seven @entity1 had @entity157 associated with @entity1575 (25 %), and 21 @entity1 were without histologically confirmed @entity82 (75 %). R0 resection was done in 18 (64 %) @entity1 . @entity532 occurred in 6 (21 %) @entity1 and reoperation due to @entity5 relapse or progression was done eight times in 6 (21 %) @entity1 . One-year and five-year @entity1 ' survivals were 64 % and 10 %, repectively, and did not statistically differ from the survival of the whole set of @entity1 with @entity5 diseases in the given time period.       In the future it will be possible to improve the long-term survival of @entity1 with @entity157 by using screening methods for presymptomatic diagnosis of @entity157 , precise preoperative diagnosis and efforts for R0 resection (Tab. 1, Fig. 4, Ref. 11).
